Cordocentesis (Percutaneous Umbilical Blood Sampling): Purpose, Procedure, Risks and What the Results Mean

Key takeaways

• Cordocentesis is a second-line, highly selective test. Amniocentesis and chorionic villus sampling answer most prenatal genetic questions with lower procedure-related risk.
• The main modern use is fetal anaemia. Cordocentesis measures fetal haemoglobin directly and allows intrauterine transfusion in the same sitting.
• Cordocentesis carries a higher fetal loss and complication rate than amniocentesis, and should be performed only by an experienced fetal medicine team.
• A normal cordocentesis result does not exclude all fetal problems. It answers only the specific question tested.
• In India, every prenatal ultrasound and ultrasound-guided fetal procedure is governed by the PC-PNDT Act, 1994: fetal sex is never disclosed.

At a glance

Also known as

• Percutaneous umbilical blood sampling (PUBS)
• Fetal blood sampling (FBS)
• Umbilical cord blood sampling in pregnancy
• Commonly described in Indian clinics as "cord blood test during pregnancy" or "cord se blood test", this is different from umbilical cord blood banking, which is collection of cord blood after delivery for stem cell storage

What cordocentesis is

Cordocentesis is an invasive prenatal diagnostic and therapeutic procedure. After a detailed scan to check fetal position, placental site and the course of the umbilical cord, the fetal medicine specialist cleans the abdomen, infiltrates local anaesthetic, and advances a fine spinal-type needle into the umbilical vein, usually at the placental cord insertion, where the cord is most stable. A small volume of fetal blood is aspirated. The sample is checked immediately to confirm it is fetal (not maternal) blood, typically using a rapid haematology analyser.

Because cordocentesis samples fetal blood directly, it can provide information that amniotic fluid or placental tissue cannot, most importantly, the actual fetal haemoglobin and platelet count. The same needle access also allows treatment: red cells or platelets can be transfused into the fetal circulation.

Why cordocentesis is done

• Suspected fetal anaemia: for example red cell alloimmunisation (Rh D, anti-c, anti-Kell), parvovirus B19 infection, or fetomaternal haemorrhage, usually after a middle cerebral artery peak systolic velocity Doppler suggests anaemia. Cordocentesis confirms the fetal haemoglobin and allows immediate intrauterine transfusion.
• Fetal and neonatal alloimmune thrombocytopenia: to measure fetal platelets or deliver a platelet transfusion in selected cases.
• Rapid fetal karyotype or genetic testing when amniocentesis or CVS is not possible, has failed, or has given an ambiguous or mosaic result that needs clarification late in pregnancy.
• Suspected fetal infection in selected situations, when amniotic fluid PCR is inconclusive and fetal haematological or serological information will change management.
• Selected inherited haematological disorders where fetal blood analysis is required, relevant in India for some haemoglobinopathy scenarios when DNA-based testing on CVS or amniotic fluid is not informative.

Who should consider cordocentesis

Cordocentesis is not a screening test and is never offered routinely. Discussion with a fetal medicine specialist is appropriate when:

• Doppler studies or hydrops suggest significant fetal anaemia.
• You have red cell antibodies (such as anti-D or anti-Kell) with rising titres and Doppler evidence of anaemia.
• There is a previous pregnancy affected by severe alloimmune anaemia or thrombocytopenia.
• A rapid fetal chromosome result is needed in the late second or third trimester, and non-invasive or other invasive options are unsuitable.
• A previous invasive test gave an unclear result (for example, suspected placental mosaicism) that must be resolved.

Cordocentesis is generally avoided or deferred where the risk outweighs benefit, for example, active maternal infection at the puncture site, uncontrolled maternal bleeding disorders, or when the information would not change management. Your fetal medicine team will weigh these individually. Results and outcomes vary depending on individual clinical circumstances.

What cordocentesis cannot detect or exclude

• It does not screen for everything. Cordocentesis answers only the specific laboratory question requested. A normal karyotype does not exclude single-gene disorders, microdeletions not covered by the test used, or metabolic conditions.
• A normal karyotype does not exclude structural birth defects. Heart defects, neural tube defects, limb and facial anomalies are detected by ultrasound and fetal echocardiography, not by fetal blood analysis.
• It does not predict neurodevelopmental outcome. Fetal blood testing cannot tell you how a child will develop, learn or behave.
• A negative infection test is not proof of no infection. Fetal antibody responses may not have developed yet, and viral load can be below detection. "Not identified" is not the same as "excluded".
• Haemoglobin is a snapshot. A normal fetal haemoglobin today does not exclude anaemia developing later; serial Doppler surveillance continues.
• It does not assess placental function over time: that needs growth scans and Doppler studies.
• Fetal sex is never reported in India, whatever the test finds, under the PC-PNDT Act.

If symptoms or scan concerns persist despite a normal cordocentesis result, go back to your obstetrician or fetal medicine specialist rather than assuming all is well.

Related but different examinations

These tests answer different questions. None is universally "better". The right choice depends on gestational age, the clinical problem, and whether treatment may be needed at the same sitting.

How to prepare

Preparation details, fasting rules, admission timing and consent paperwork are decided by the unit performing the procedure. Your unit's written instructions take precedence over anything you read here.

• Counselling and consent: you should have a detailed discussion of why cordocentesis is being offered, what alternatives exist, and what will and will not be tested.
• Maternal blood tests: blood group and Rh typing, antibody screen, and often haemoglobin and infection serology, are usually arranged beforehand.
• Medicines: tell the team about everything you take, including blood thinners, aspirin, low-molecular-weight heparin, insulin or other diabetes medicines, and any AYUSH or herbal preparations. Do not stop or change any prescribed medicine yourself, ask the prescriber.
• Skin: avoid applying oils, lotions or creams to the abdomen on the day.
• Fasting: often not required, but some units ask for light fasting when sedation or a longer transfusion procedure is planned. Follow your unit's instruction.
• Support and transport: arrange for someone to accompany you home, particularly if sedation is used.

If you have diabetes on glucose-lowering treatment

If your unit asks you to fast, tell the team in advance. Insulin and some oral medicines can cause low blood sugar during a fast in pregnancy. The diabetes team should advise on dose timing; do not adjust doses on your own.

If you take anticoagulants or antiplatelet medicines

These affect bleeding risk at the needle site. The obstetric and haematology teams will plan timing together. Never pause or restart these medicines without instruction.

If you are Rh D negative

Cordocentesis can cause fetomaternal haemorrhage. Anti-D immunoglobulin is usually given after the procedure for Rh D negative women who are not already alloimmunised, as per your unit's protocol.

If you have anaemia, thalassaemia trait or a haemoglobinopathy

These are common in several Indian communities and are relevant both to your own health and to the genetic question being asked. Carry any previous haemoglobin electrophoresis or HPLC reports and partner testing results.

What happens during cordocentesis

• Detailed scan first: the specialist maps the placenta, the cord insertion and fetal position, and chooses the safest needle path.
• Skin cleaning and local anaesthetic: the abdomen is cleaned with antiseptic and draped; local anaesthetic is usually infiltrated into the skin and abdominal wall.
• Needle insertion: a fine needle is advanced under continuous ultrasound vision into the umbilical vein. Most women describe pressure and a brief sharp sensation rather than severe pain.
• Sampling: a small volume of fetal blood is withdrawn and immediately checked to confirm it is fetal blood.
• Treatment if planned: if fetal anaemia is confirmed, an intrauterine transfusion may be given through the same needle. This extends the procedure considerably.
• Monitoring afterwards: the fetal heart rate and the puncture site are observed by ultrasound, and you are usually monitored for a period before discharge.

How long does cordocentesis take

The needle part of a straightforward diagnostic cordocentesis is often over within a few minutes. Including the preparatory scan, consent, positioning and post-procedure observation, expect the hospital visit to last roughly one to two hours. If an intrauterine transfusion is performed, the procedure itself may take considerably longer and observation is extended, sometimes with an overnight stay. Difficult fetal or cord position can lengthen the procedure or lead the team to reschedule it.

Laboratory turnaround differs by the test requested: an immediate fetal haemoglobin and platelet count is available within minutes on a bedside analyser, rapid chromosome tests such as FISH or QF-PCR usually take a small number of days, and full karyotype or specialised genetic panels take longer. Ask your unit for its own timelines.

Understanding your report

Cordocentesis reports are not self-explanatory and should always be interpreted by the fetal medicine specialist who requested the test, alongside your scans and history.

• Fetal haemoglobin and haematocrit: interpreted against gestation-specific norms, because normal fetal haemoglobin changes with gestational age. A value that looks low by adult standards may be appropriate for the gestation, and vice versa.
• Platelet count: a low fetal platelet count may indicate alloimmune thrombocytopenia and changes delivery planning.
• Karyotype or chromosomal microarray: reported as normal, abnormal, or as a variant of uncertain significance. Variants of uncertain significance are common and need genetic counselling rather than immediate conclusions.
• Infection testing: fetal IgM or PCR results are interpreted with maternal serology and scan findings, never alone.
• Blood group and Coombs testing may be included where alloimmunisation is the concern.

No prenatal blood result should be acted on without counselling. Decisions about ongoing pregnancy management in India are also governed by the applicable legal framework, and your team will explain what is available.

When results can be misleading

Falsely reassuring (normal result despite a real problem)

• Dilution with amniotic fluid or maternal blood can alter measured fetal haemoglobin. Units run purity checks for this reason, but contamination can still affect interpretation.
• Timing of infection testing: fetal IgM may be absent early after infection, giving a negative result in a genuinely infected fetus.
• A normal karyotype does not exclude single-gene disorders or structural anomalies.
• A single normal haemoglobin can be followed by rapid deterioration in active alloimmunisation, so surveillance continues.

Falsely alarming (abnormal-looking result that is not what it seems)

• Maternal blood contamination can make the sample appear normal when the fetus is anaemic, or confuse genetic results by reporting maternal rather than fetal DNA.
• Mosaicism in the sample may not reflect the fetus as a whole and often requires further testing and counselling.
• Transient bradycardia seen immediately after the needle is withdrawn is common and usually settles; it is not by itself evidence of harm.
• Platelet clumping or a delayed sample can artefactually lower the reported platelet count.

Risks and safety

Cordocentesis carries a higher risk of pregnancy loss and complications than amniocentesis or CVS, and is offered only where the information or treatment justifies it. Risk depends on gestational age, the indication, whether the fetus is already unwell or hydropic, cord access, and the operator's experience. Risk figures quoted in published series vary widely and should be discussed with your own team using their data and your specific situation.

Risks of diagnostic cordocentesis

• Bleeding from the cord puncture site, usually brief
• Fetal bradycardia, usually transient
• Fetomaternal haemorrhage, which can worsen alloimmunisation
• Infection (uncommon)
• Rupture of membranes, preterm labour, or pregnancy loss
• Failure to obtain an adequate sample, requiring a repeat attempt

Additional risks when intrauterine transfusion is performed

Transfusion lengthens needle time and adds risks of volume overload, cord haematoma and transfusion reactions. However, in severe fetal anaemia the alternative, no treatment, carries a substantially higher risk to the fetus. This balance is a specialist discussion.

Maternal risks

Discomfort, bruising, and rarely infection or bleeding at the needle site. Rh D negative women usually require anti-D prophylaxis afterwards.

Special situations

Pregnancy-specific considerations

Cordocentesis is by definition a pregnancy procedure. Gestational age matters: before about 18 weeks the cord vessels are small and the technical difficulty and risk rise, which is why amniocentesis or CVS is preferred for earlier genetic diagnosis. Twin pregnancies require careful mapping to be certain which cord is being sampled.

Rh D negative and alloimmunised pregnancies

Alloimmunisation is one of the main reasons cordocentesis is performed. Because the procedure can worsen sensitisation, most teams rely on middle cerebral artery Doppler to decide when cordocentesis is truly needed, rather than sampling repeatedly.

Women with chronic kidney disease, heart disease or fluid restriction

Any fasting instruction, intravenous fluid or sedation must be adjusted. Tell the team about heart failure, rheumatic or other valvular heart disease, CKD, or a prescribed fluid restriction before the appointment date.

Women with bleeding or clotting disorders

Platelet counts, clotting studies and anticoagulant timing are planned jointly with haematology.

Women with hepatitis B, hepatitis C or HIV

Invasive procedures can carry a risk of transmitting infection to the fetus. The team will assess viral load and treatment status and may advise against the procedure or take specific precautions.

Cordocentesis in the Indian context

• PC-PNDT Act, 1994: all prenatal ultrasound and ultrasound-guided fetal procedures in India fall under this law. Registered centres, trained operators, mandatory forms and record-keeping are required, and communicating fetal sex in any form is a criminal offence. You will be asked to complete the prescribed declaration.
• Availability: cordocentesis is performed only at fetal medicine units with trained operators and immediate access to a laboratory and neonatal support. It is not a district-level service, and referral is usual.
• Haemoglobinopathies: beta-thalassaemia trait, sickle cell disease and HbE are common in several Indian populations. Most prenatal diagnosis for these is done by DNA analysis on CVS or amniotic fluid; fetal blood sampling is reserved for selected situations where DNA testing is uninformative.
• Rh D negative pregnancies: anti-D prophylaxis coverage is uneven across the country, and alloimmunised pregnancies requiring intrauterine transfusion are still seen regularly at Indian tertiary centres.
• Infections: parvovirus B19, cytomegalovirus, toxoplasmosis and syphilis remain relevant causes of fetal anaemia or hydrops and may prompt fetal medicine referral.
• Iron-deficiency anaemia in mothers is very common in India but is a maternal issue; it is not an indication for cordocentesis.

Cost and insurance in India

Charges for cordocentesis vary considerably between cities, between government and private hospitals, and with what is done at the same sitting. Ask for a written estimate before the procedure.

• Procedure fee: the fetal medicine specialist's charge, ultrasound guidance, day-care or theatre use and consumables.
• Laboratory tests: a bedside fetal haemogram costs far less than karyotype, chromosomal microarray, targeted gene sequencing or infection PCR panels. Genetic tests are usually the largest component.
• Intrauterine transfusion: adds irradiated, cross-matched blood product costs, longer theatre time and extended monitoring.
• Pre- and post-procedure care: counselling, anti-D immunoglobulin, follow-up scans and any admission.
• Insurance: cover for prenatal diagnostic procedures differs widely between policies and often depends on whether maternity benefits are active and whether the procedure is classed as diagnostic or therapeutic. Confirm with your insurer and the hospital's insurance desk in advance.

Some state and government programmes subsidise prenatal diagnosis for haemoglobinopathies; ask your treating unit what applies locally.

Myths and facts

Frequently asked questions

What is cordocentesis used for?

Cordocentesis is used mainly to measure fetal haemoglobin when anaemia is suspected and to deliver intrauterine transfusion. Other uses include measuring fetal platelets, obtaining a rapid fetal karyotype when other invasive tests are unsuitable or inconclusive, and investigating selected fetal infections. It is always a specialist, indication-driven procedure.

Is cordocentesis painful?

Most women describe pressure and a brief sharp sensation rather than severe pain. Local anaesthetic is usually infiltrated into the abdominal wall. Some soreness or bruising at the needle site for a day or two is normal. Tell the team immediately if pain becomes severe or persistent during or after the procedure.

When in pregnancy is cordocentesis performed?

Cordocentesis is generally performed after about 18 to 20 weeks of gestation, once the umbilical vessels are large enough to target safely. Earlier attempts are technically harder and riskier, which is why chorionic villus sampling or amniocentesis is preferred when the question is genetic and can be answered earlier.

How soon will I get the results?

It depends on the test. Fetal haemoglobin and platelet counts are available within minutes on a bedside analyser, which is what allows transfusion in the same sitting. Rapid chromosome tests such as FISH or QF-PCR take a few days, and full karyotype, microarray or gene panels take longer. Ask your unit for its own timelines.

How risky is cordocentesis compared with amniocentesis?

Cordocentesis carries a higher risk of pregnancy loss and complications than amniocentesis. Reported risk varies with gestation, indication, whether the fetus is already unwell, cord access and operator experience. Your fetal medicine team should discuss the figures relevant to your situation rather than a single general number.

Can cordocentesis detect all genetic conditions?

No. Cordocentesis detects only what the requested test looks for. A normal karyotype does not exclude single-gene disorders, small chromosomal deletions outside the test's range, metabolic conditions, or structural anomalies. Structural problems are identified by detailed ultrasound and fetal echocardiography, not by fetal blood analysis.

Will I be told the baby's sex?

No. Under the PC-PNDT Act, 1994, disclosing fetal sex during pregnancy is illegal in India, regardless of how the information was obtained. Reports are issued in a way that complies with this law, and clinicians, laboratories and sonologists are legally prohibited from communicating fetal sex to anyone.

What happens if the result is abnormal?

The next step depends entirely on the finding. Confirmed fetal anaemia may be treated with intrauterine transfusion, sometimes repeatedly. A genetic finding leads to genetic counselling, further testing where appropriate, and planning for delivery and newborn care. Fetal infection is managed with monitoring and, in some cases, specific treatment.

Do I need bed rest afterwards?

Most units advise taking it easy and avoiding strenuous activity for a short period, but prolonged bed rest is not usually required. Follow the specific instructions from your unit. Contact the team promptly if you develop bleeding, fluid leakage, fever, persistent pain or reduced fetal movements.

Sources

• Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994 and Rules, Government of India, Ministry of Health and Family Welfare.
• Royal College of Obstetricians and Gynaecologists, Green-top Guideline on amniocentesis and chorionic villus sampling.
• Royal College of Obstetricians and Gynaecologists, Green-top Guideline on the management of women with red cell antibodies during pregnancy.
• Society for Maternal-Fetal Medicine, clinical guidance on the diagnosis and management of fetal anaemia and intrauterine transfusion.
• Federation of Obstetric and Gynaecological Societies of India (FOGSI), good clinical practice recommendations on prenatal diagnosis and Rh alloimmunisation.
• Indian Council of Medical Research, national guidance on prenatal diagnosis of haemoglobinopathies.